International Medical Products Anti-CounterfeitingTaskforce.

Slides:



Advertisements
Similar presentations
الرابطة الدولية لمكافحة المواد الطبيّة المزورة a WHO initiative to combat counterfeit medical products Dr V. Reggi - World Health Organization.
Advertisements

Overview of the medicine prices and availability survey methodology Presentation template for adaptation and use in medicine prices and availability survey.
Combating counterfeit medicines in Vietnam. Issues Definitions of counterfeit medicines and concerned legal documents National coordination Number of.
Copyright of the Health Sciences Authority 2007 ASEAN-China Conference on Combating Counterfeit Medical Products Jakarta, November 2007 Singapore.
Combating Counterfeit Drugs in China Chen Xu Ph.D. Director of Division of Drug Supervision and Inspection Department of Drug Market.
International Medical Products Anti-CounterfeitingTaskforce INSPECTOR OF DRUGS NATIONAL DRUG AUTHORITY- UGANDA.
COMBATING COUNTERFEIT DRUGS IN INDONESIA
International Medical Products Anti-CounterfeitingTaskforce.
International Medical Products Anti-CounterfeitingTaskforce.
IMPACT REGIONAL CONFERENCE ON COMBATING COUNTERFEIT MEDICAL PRODUCT: 9-10 NOVEMBER 2009: KEMPTON PARK,SOUTH AFRICA: BY DETECTIVE INSPECTOR NAMIBIA.
International Medical Products Anti-CounterfeitingTaskforce.
International Medical Products Anti-CounterfeitingTaskforce.
WHO Good Distribution Practices for Pharmaceutical Products
First ASEAN-China Conference on Combating Counterfeit Medical Products Jakarta November 2007 CHOO CHEOK HANG DEPARTMENT OF PHARMACEUTICAL SERVICES.
1 WTO SEMINAR ON TECHNICAL ASSISTANCE ON CUSTOMS VALUATION CHALLENGES TO IMPLEMENTING THE AGREEMENT ON CUSTOMS VALUATION PRESENTATION BY: REUBEN K. KUNDA.
1 The Experience of Private Hospitals In the Republic of Yemen Success and Problems Dr. Ali K. Abbas Yemen International Health & Education Consultants.
DG Enterprise and Industry Approach on Combating Counterfeit Medicines Council of Europe Conference “Europe against Counterfeit Medicines” Session: Key.
Panel themes of the International Conference “Europe against Counterfeit Medicines” G.N. Gildeeva, Deputy head of the Department of Registration of Medicines.
@DiscoverForums DiscoverForums Healthcare in Vietnam Estimated market size US$ 265 mil in 2014 Market growth approximately 12% between
Strengthening the Protection of Intellectual and Industrial Property Rights Deputy Manager Jan Hylleberg The Danish Association of the Pharmaceutical Industry.
V Conference of the Pan American Network for Drug Regulatory Harmonization (PANDRH) 17 – 19 November 2008 Buenos Aires Argentina Beverly Reynolds CARICOM.
National Statistics Bureau Manufacturing Statistics in Seychelles Prepared by Benjamin Ciseau.
Seychelles, officially the Republic of Seychelles, is an island country spanning an archipelago of 115 islands in the Indian Ocean, some 1,500 kilometres.
ILLEGAL DRUG STORES IN ZAMBIA PRESENTED BY A. PHIRI ARTHUR DAVISON CHILDREN’S HOSPITAL Presented to CSO workshop in Ndola on 29 August 2013.
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
Pharmaceutical System Strengthening : Bangladesh Perspective Aktari Mamtaz Joint Secretary Ministry of Health and Family welfare (MOHFW), Bangladesh.
> In April of 2007, Main Pharmaceutical Inspector created special position for combating counterfeit and illegal medicines > In May,
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA. Presentation by: Dr. Joseph K. Yano B.Pharm (Nbi) L.L.B (Moi) Legal Officer Pharmacy and Poisons Board Ministry.
Use of an Indicator-Based System for Assessing, Monitoring, and Improving Pharmacy Practice Authors: Lates, J. (1); Sumbi, V. (2); Phulu, B. (1); Rushubiza,
Medicines Transparency Alliance10/10/2015 Updates on Quality Presentations et al. John Allotey Manager, Business Developments LaGray Chemical Company Limited.
And Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Challenges of Medicine Regulation in Africa Global.
The Pharmaceutical Situational Analysis in Mongolia 1 Chimedtseren Munkhdelger 1 Sanjjav Tsetsegmaa 2, 1 Ministry of Health, 2 Pharmacy School, Health.
Tanzania1. 2 Tanzania Assessment Gabriel Upunda Tanzania3 DemographicsTanzania Area (sq km)945,100 Population 32,900,000 25% urban GNP per capitaUS $240.
OVERVIEW OF THE ZIMBABWE NATIONAL MEDICINES POLICY Dr C E Ndhlovu, M Med Sci, FRCP Chairperson, NMTPAC Deputy Dean, UZCHS National workshop, Jan 22-23,
Pharmacy and Poisons Board Pharmacy and Poisons Board, Kenya Role of Regulation in Optimizing Medicine use KNH/UON Pharmacy Symposium Optimizing Medicine.
NEW NAMIBIA MEDICINES CONTROL ACT SAPRAA meeting 5 September 2008 Presented by: Johannes Gaeseb Registrar of Medicines NAMIBIA.
NRA in BTSs of the EMR Dr. Nabila E. Metwalli Regional Advisor / Blood Safety WHO / EMRO Cairo, Egypt and Dr. Abdel Aziz Saleh WHO / EMRO Advisor.
ACCESS TO MEDICINES - POLICY AND ISSUES
Zambia’s Porous Borders & the Influx of Medicines.
PRESENTATION: PORTFOLIO COMMITTEES ON CORRECTIONAL SERVICES AND HEALTH PROVISION OF HEALTH CARE WITHIN CORRECTIONAL CENTRES 1.
Objective The aim was to assess purchasing pharmaceuticals in the public health sector in Jordan through the joint procurement for participating parties.
Experience on quality of anti-malarials in Lao PDR by Dr.Somthavy CHANGVISOMMID Deputy Director of Food and Drug Department Ministry of Health, Lao PDR.
WHO-Technical Briefing Seminar | October-November 2012 Dr Cécile Macé 1 |1 | Good Governance for Medicines Programme Dr Cécile Macé EMP/MPC.
Trade & Access to Medicines in India Centre for Trade & Development
PHARMACOVIGILANCE PLAN FOR TANZANIA PREPARED BY EMMA & MARY 10 TH SEPTEMBER 2004.
Group A: Angola – Mozambique – RdC –Mauritius - Kenya G roup B: Namibia – Seychelles - South Africa - Uganda Group C: Botswana - Lesotho – Swaziland -Tanzania.
Pharmaceutical Working Group Working Group on Pharmaceuticals Key Points for Advocacy and Action.
IMPACT - Regional Meeting on Combating Counterfeit Medical Products 9-10 November 2009, Kempton Park South Africa WHO Survey on situation of counterfeit.
Control On the Imported Food in the Jordan Procedure and Strategic plan (2011 to 2015)
IPR Enforcement in the United Kingdom Kenny Wright Danish Patent and Trademark Office.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
The First Conference for Medicines Regulatory Authorities In Sudan and Neighboring Countries Khartoum December 2014 Alain PRAT, Technical Officer,
ADDRESSING PHARMACEUTICAL SUPPLY CHAIN NEEDS PRESENTATION TO HEALTH DONOR GROUP MEETING 8 July 2009.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Quality of Drugs in Private Pharmacies in Laos: A Repeated Study in 1997 and 1999 Stålsby Lundborg C, Syhakhang L, Lindgren B, Tomson G International Health.
THE ROLE OF NON CUSTOMS AGENCIES IN A FULLY FLEDGED CUSTOMS UNION, EAC FORUM ON CUSTOMS UNION By Dr. Terry Kahuma, Executive Director, UNBS.
Forest cover and Land Use of Lao PDR During 1982, 1992 and 2002 Prepared and Presented by: Mr. Vongdeuane VONGSIHARATH, D.DG Deparment of Land Planning.
ROLES AND RESPONSIBILITIES OF TFDA ON ADDO PROGRAM
ACCESS TO QUALITY MEDICINES IN THE REGION-COUNTERFEITING PROBLEMS
WHO Medicines Work in Countries: The Kenya Example
East African Drug Seller Initiative Uganda Sensitization Meeting
Quality Control Laboratories; Challenges from A Regulatory perspective
Technical Assistance and Capacity Building Activities in SADC
Development in Law Enforcement of IP in Cambodia
Issues on Dispensing Dr Percy Mahlathi.
Dr Manisha Shridhar Regional Advisor WHO-SEARO
Syhakhang L, Stenson B, Stålsby LC, Eriksson B, Tomson G
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA
WORKSHOP ON OPTIMAL PROCUREMENT OF AFFORDABLE AND QUALITY ASSURED LIFE-SAVING COMMODITIES FOR MATERNAL HEALTH KAMPALA, UGANDA - REGULATORY STATUS AND QUALITY.
SECURITY AND RISK MANAGEMENT CONSULTANT
Presentation transcript:

International Medical Products Anti-CounterfeitingTaskforce

Map of Seychelles

Introduction Seychelles consists of about 115 islands situated in the western Indian oceanSeychelles consists of about 115 islands situated in the western Indian ocean The major islands of Seychelles are located 1000 miles (1600 km) east of KenyaThe major islands of Seychelles are located 1000 miles (1600 km) east of Kenya The main islands are Mahe, Praslin and La Digue. The capital is VictoriaThe main islands are Mahe, Praslin and La Digue. The capital is Victoria Seychelles has a population of about 85000Seychelles has a population of about 85000

Introduction Cont., The total area of Seychelles islands are 175 square miles (453 square km)The total area of Seychelles islands are 175 square miles (453 square km) The climate is tropical oceanic with little temperature variation during the year.The climate is tropical oceanic with little temperature variation during the year.Education School system is free for the nine year of primary and secondary educationSchool system is free for the nine year of primary and secondary education

Health System Health is freeHealth is free Seven private doctors with dispensing facilitiesSeven private doctors with dispensing facilities Four private pharmacies and few health care shopsFour private pharmacies and few health care shops Majority of medicines are distributed by Government pharmaciesMajority of medicines are distributed by Government pharmacies Medicines imported by Ministry of Health (MOH) are tested during pre-marketing and post marketing surveillance by National Drug Quality Control Laboratory (NDQCL)Medicines imported by Ministry of Health (MOH) are tested during pre-marketing and post marketing surveillance by National Drug Quality Control Laboratory (NDQCL) The NDQCL was established in 2001The NDQCL was established in 2001

Health System Cont., Medicines imported by MOH are mainly generic items whereas private pharmacies mostly target branded itemsMedicines imported by MOH are mainly generic items whereas private pharmacies mostly target branded items MOH buys its medicines directly from the manufacturers for exportMOH buys its medicines directly from the manufacturers for export There is only one International Air port and most medicines imported by MOH comes via airThere is only one International Air port and most medicines imported by MOH comes via air Private pharmacies target parallel marketPrivate pharmacies target parallel market Medicines imported by Private or NGOs are not tested at NDQCL due to lack of LegislationsMedicines imported by Private or NGOs are not tested at NDQCL due to lack of Legislations

In the past years there were no seizure of counterfeit medicinesIn the past years there were no seizure of counterfeit medicines –No Legislation in place –Inadequate drug registration system –Absence of CM in the country Seychelles is not aware of the WHOs Rapid Alert System Definition of counterfeit medical product used in Seychelles

Seychelles Pharmacy Act is outdatedSeychelles Pharmacy Act is outdated Currently we are in the process of getting the WHOs consultants to review the National Medicine Legislation and Regulatory FrameworkCurrently we are in the process of getting the WHOs consultants to review the National Medicine Legislation and Regulatory Framework In the new Pharmacy Legislations, the following be in cooperated : Definition of CM, Cooperation between national authorities and stake holders, Regional and International cooperation, Strengthening the operational capacity of the medicines regulatory authority, Criminalizing the trade of CM and more severe sanctions for crimes related to CMIn the new Pharmacy Legislations, the following be in cooperated : Definition of CM, Cooperation between national authorities and stake holders, Regional and International cooperation, Strengthening the operational capacity of the medicines regulatory authority, Criminalizing the trade of CM and more severe sanctions for crimes related to CM Our National Legislation

There is a Medicines Regulatory Authority (MRA) unit within the Pharmaceutical Services under the MOHThere is a Medicines Regulatory Authority (MRA) unit within the Pharmaceutical Services under the MOH Only issues permits for private and NGOs for importing medicines Only issues permits for private and NGOs for importing medicines Inspection of Pharmacy premises together with licensing authority Inspection of Pharmacy premises together with licensing authority No registration of medicines No registration of medicines Public sector uses open permit system for importing medicines and its renewed annuallyPublic sector uses open permit system for importing medicines and its renewed annually For the year 2007, MRA issuedFor the year 2007, MRA issued 655 permits to private sectors 655 permits to private sectors 5 permits to NGOs 5 permits to NGOs National coordination

Free Trade Zone In Seychelles the free trade zone is only for export marketIn Seychelles the free trade zone is only for export market The free trade zone are under the supervision of MRA but inadequate human resources makes it difficult to supervise frequentlyThe free trade zone are under the supervision of MRA but inadequate human resources makes it difficult to supervise frequently The National Pharmaceutical Legislations is applicable for the free trade zoneThe National Pharmaceutical Legislations is applicable for the free trade zone In 2008, there were two pharmaceutical inspections carried outIn 2008, there were two pharmaceutical inspections carried out

Market Control In 2007, the total number of samples collected from public sector were 313In 2007, the total number of samples collected from public sector were 313 All the 313 samples were tested at NDQCLAll the 313 samples were tested at NDQCL There are no informal market for medicines in SeychellesThere are no informal market for medicines in Seychelles

Number of cases SuspectedConfirmedImported / DomesticVital Medicines How where these cases detected? number of cases Patients complaints Health professionals reports Enforcement/investigation work Routine checks Reported by affected manufacturer/importer Other

So far MOH has not encountered with Counterfeit MedicinesSo far MOH has not encountered with Counterfeit Medicines Possibly in private sectors counterfeit medicines may existPossibly in private sectors counterfeit medicines may exist Nothing could be done until the National Medicine Legislation and Regulatory Framework is establishedNothing could be done until the National Medicine Legislation and Regulatory Framework is established Seychelles will support any proposal that will help to combat counterfeit medicinesSeychelles will support any proposal that will help to combat counterfeit medicines Conclusion